Hematologic Malignancy
B Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
CI-CAN-00004540Explore in graph →
Hematologic3 active trials80 evidence items
- NCIt
- C129787
- OncoTree
- BLLBCRABL1L
- DOID
- 0080650
- UMLS CUI
- C4329382
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00004540Explore in graph →
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | completed | Phase 3 | 5,949 | National Cancer Institute (NCI)NIH | 7 | Jun 2, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jun 2, 2026source: clinicaltrials